Biotechnology - Politics, Pricing

Filter

Current filters:

PoliticsPricing

Popular Filters

US lawmakers question price of Gilead’s Sovaldi

US lawmakers question price of Gilead’s Sovaldi

24-03-2014

Three leading US Congressmen have written to John Martin, chief executive of US biotech firm Gilead Sciences,…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPoliticsPricingRegulationSovaldiUSA

UK’s BIA finds government unwilling to set price cap for orphan disease treatment

UK’s BIA finds government unwilling to set price cap for orphan disease treatment

11-03-2014

The majority of Members of Parliament in the UK believe there should not be a maximum price per patient…

BiotechnologyPoliticsPricingRare diseasesUK

UK's value-based pricing system plans lack clarity, MPs find

17-01-2013

The UK government's plans to overhaul the National Health Service pricing system for new drugs are poorly…

BiotechnologyEuropePharmaceuticalPoliticsPricingResearch

EMIG calls for greater clarity on value-based medicines from UK Parliamentary inquiry into NICE

31-10-2012

The UK Ethical Medicines Industry Group (EMIG) has welcomed the House of Commons Health Select Committee's…

BiotechnologyEuropePharmaceuticalPoliticsPricingRegulation

Confidential pricing agreements mitigate risks of low drug prices in key markets

18-10-2012

Pharmaceutical brand teams design their global launch sequencing strategies to mitigate the risks associated…

BiotechnologyGlobalPharmaceuticalPoliticsPricing

EFPIA welcomes Commission policy strategy agenda to strengthen Pharma competitiveness

12-10-2012

The European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomes the European Commission…

BiotechnologyEuropeMarkets & MarketingPatentsPharmaceuticalPoliticsPricing

European governments' austerity pricing tactics support generic drug growth

09-07-2012

Government initiatives to cut health expenditure are likely to encourage sales of generic medications…

BiotechnologyEuropeGenericsMarkets & MarketingPoliticsPricing

German model for assessment of new medicines slammed by EU pharma leaders

11-06-2012

Leading pharmaceutical companies in Europe, represented in the European Federation of Pharmaceutical…

BiotechnologyEuropePharmaceuticalPoliticsPricingRegulation

UK pharma industry head fears for future of UK medical research

06-06-2012

The UK government is too focused on encouraging "breakthrough drugs" at the expense of significant gains…

BiotechnologyEuropePharmaceuticalPoliticsPricingResearch

Biopharmaceuticals "no longer a growth market" in Germany

30-04-2012

After years of consistent growth, the German biopharmaceuticals market came to a juddering halt last…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalPoliticsPricingRegulation

Back to top